S
Septerna, Inc. Common Stock (SEPN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
$41.67
-0.93 (-2.18%)
Market Cap: $2.03B
Last updated: Nov 17, 2026 at 11:06 AM ET
Septerna, Inc. Common Stock (SEPN) Valuation Multiples
Septerna, Inc. Common Stock (SEPN) trades at 20.3x sales and 4.6x book value. Its forward P/E is 107.5x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 107.5x |
| Price to sales | 20.3x |
| Price to book | 4.6x |
|---|---|
| PEG | N/A |
As of Nov 17, 2026
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About SEPN
What is SEPN's forward P/E ratio?
Septerna, Inc. Common Stock has a forward P/E ratio of 107.5x.
Is SEPN stock overvalued?
GNG's valuation label for SEPN is Fairly valued.
What is SEPN's price to sales ratio?
Septerna, Inc. Common Stock has a price to sales ratio of 20.3x.
SEPN pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors